Cover Image
市場調查報告書

腸癌:全球臨床實驗趨勢

Intestinal Cancer Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 328414
出版日期 內容資訊 英文 247 Pages
訂單完成後即時交付
價格
Back to Top
腸癌:全球臨床實驗趨勢 Intestinal Cancer Global Clinical Trials Review, H1, 2015
出版日期: 2015年02月27日 內容資訊: 英文 247 Pages
簡介

本報告提供全球腸癌治療藥臨床實驗相關調查,提供您各地區的臨床試驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗資料,中斷 (暫時停止、廢止、停止) 的實驗清單等資訊。

簡介

  • 腸癌
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:癌症治療藥臨床實驗上腸癌的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:癌症治療藥臨床實驗上腸癌的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

腸癌治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Sanofi
    • Pfizer Inc.
    • Amgen Inc.
    • Novartis AG
    • Bristol-Myers Squibb Company
    • AstraZeneca PLC
    • E. Merck KG
    • 大塚集團
    • Bayer AG
  • 有代表性的研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Memorial Sloan Kettering Cancer Center
    • University of Texas M. D. Anderson Cancer Center
    • European Organization for Research and Treatment of Cancer
    • Sun Yat-sen University
    • FUDAN University
    • Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
    • Cancer Research UK
    • City of Hope
    • NCIC Clinical Trials Group

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2586CTIDB

GlobalData's clinical trial report, "Intestinal Cancer Global Clinical Trials Review, H1, 2015" provides data on the Intestinal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Intestinal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Intestinal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Intestinal Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Intestinal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Intestinal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Intestinal Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Intestinal Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • E. Merck KG
      • Clinical Trial Overview of E. Merck KG
      • Otsuka Holdings Co., Ltd.
      • Clinical Trial Overview of Otsuka Holdings Co., Ltd.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • Sun Yat-sen University
      • Clinical Trial Overview of Sun Yat-sen University
      • FUDAN University
      • Clinical Trial Overview of FUDAN University
      • Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
      • Clinical Trial Overview of Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
      • Cancer Research UK
      • Clinical Trial Overview of Cancer Research UK
      • City of Hope
      • Clinical Trial Overview of City of Hope
      • NCIC Clinical Trials Group
      • Clinical Trial Overview of NCIC Clinical Trials Group
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Intestinal Cancer Therapeutics, Global, Clinical Trials by Region, 2015*
  • Intestinal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Intestinal Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Intestinal Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Intestinal Cancer Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Intestinal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Intestinal Cancer Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Intestinal Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Intestinal Cancer Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Intestinal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Research UK, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by NCIC Clinical Trials Group, 2015*

List of Figures

  • Intestinal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Intestinal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Intestinal Cancer to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Intestinal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Intestinal Cancer to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Intestinal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Intestinal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Intestinal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Intestinal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Intestinal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Intestinal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top